2052
C. Pillard et al.
PAPER
N-(3-Iodopyridin-2-yl)-2,2-dimethylpropionamide (9)
H-6 trans), 8.27 (d, J = 2.1 Hz, 1 H, H-4 cis), 8.39 (d, J = 2.1 Hz,
1 H, H-6 cis).
To a stirred solution of n-BuLi (1.6 M in hexane, 210 mL, 337
mmol) was added dropwise at –40 °C a solution of 2,2-dimethyl-N-
pyridin-2-yl-propionamide (20 g, 112 mmol) in THF (70 mL). After
4 h of stirring at –10 °C, the mixture was cooled to –78 °C and a so-
lution of I2 (60 g, 236 mmol) in THF (80 mL) was added via a drop-
ping funnel. After 1 h, the reaction mixture was allowed to reach r.t.,
quenched with sat. NaHCO3 (100 mL) and extracted with CH2Cl2
(3 × 100 mL). The combined organic layers were dried over
MgSO4, filtered and evaporated. The crude product was recrystal-
lised (CH2Cl2–pentane) to give the title compound. The analytical
data were in accordance with literature values.13
N-5-Bromo-3-(1-ethoxyvinylpyridin-2-yl)-2,2-dimethylpropi-
onamide (14)
1H NMR (250 MHz, CDCl3): d = 1.35 (m, 12 H, CH3), 3.92 (q,
J = 7.0 Hz, 2 H, CH2), 4.48 (s, 2 H, CH2), 7.76 (d, J = 2.1 Hz, 1 H,
H-4), 7.95 (br s, 1 H, NH), 8.48 (d, J = 2.1 Hz, 1 H, H-6).
The mixture of enol ethers 13 and 14 was dissolved in aq H2SO4
(10%; 75 mL) and heated to reflux for 5 h. The reaction was basified
with NaOH to pH 9 and extracted with EtOAc (2 × 50 mL). The
combined organic layers were dried over MgSO4, filtered and evap-
orated to obtain a mixture of azaindole 8 and ketone 15. To a solu-
tion of this crude mixture in MeOH (150 mL) was added,
portionwise, NaBH4 (0.360 mg, 9.5 mmol). The resulting solution
was stirred for 24 h at r.t. then quenched with H2O (15 mL). MeOH
was evaporated under reduced pressure and the residue was extract-
ed with CH2Cl2 (2 × 100 mL). The combined organic layers were
dried over MgSO4, filtered and evaporated to give the crude prod-
uct, which was purified by flash chromatography on silica gel (PE–
EtOAc–Et3N, 3:2:1 then CH2Cl2–MeOH, 9:1) to give the desired
product 8 and alcohol 16. The analytical data were in accordance
with literature values.12
Yield: 23.8 g (70%); white solid; mp 147–148 °C.
IR (KBr): 3298, 3044, 2974, 2934, 2874, 1670 cm–1.
1H NMR (250 MHz, CDCl3): d = 1.37 (s, 9 H, 3 × CH3), 6.84 (dd,
J = 4.9, 7.8 Hz, 1 H, H-5), 7.92 (br s, 1 H, NH), 8.11 (dd, J = 1.5,
7.8 Hz, 1 H, H-4), 8.45 (dd, J = 1.5, 4.9 Hz, 1 H, H-6).
13C NMR (63 MHz, CDCl3): d = 27.5 (CH3), 40.1 (Cq), 88.2 (Cq),
121.7 (C-5), 147.9 (C-4), 148.3 (C-6), 151.1 (Cq), 176.0 (Cq).
N-(5-Bromo-3-iodopyridin-2-yl)-2,2-dimethylpropionamide
(10)
To a stirred solution of N-(3-iodopyridin-2-yl)-2,2-dimethylpropi-
onamide (9; 12 g, 39.5 mmol) in DMF (54 mL) was added Br2 (5.07
mL, 98.7 mmol) via a dropping funnel. After 24 h of stirring at r.t.,
the solvent was removed under reduced pressure. The resulting oil
was dissolved in CH2Cl2 (50 mL) and washed with Na2S2O3 solu-
tion (5%; 2 × 20 mL). The organic layer was dried over MgSO4, fil-
tered and evaporated to give 10.
5-Bromo-1H-pyrrolo[2,3-b]pyridine (8)
Yield: 231 mg (45% over 3 steps); white solid; mp 174–176 °C
IR (KBr): 3136 cm–1.
1H NMR (250 MHz, CDCl3): d = 6.47 (d, J = 3.5 Hz, 1 H, H-3),
7.37 (d, J = 3.5 Hz, 1 H, H-2), 8.08 (d, J = 2.2 Hz, 1 H, H-4), 8.36
(d, J = 2.2 Hz, 1 H, H-6), 10.13 (br s, 1 H, NH).
13C NMR (63 MHz, CDCl3): d = 100.6 (C-3), 111.7 (Cq), 122.2 (Cq),
126.8 (C-2), 131.3 (C-4), 143.2 (C-6), 147.1 (Cq).
Yield: 13.9 g (92%); white solid; mp 192–194 °C.
IR (KBr): 3298, 1670 cm–1.
1H NMR (250 MHz, CDCl3): d = 1.36 (s, 9 H, 3 × CH3), 7.89 (br s,
1 H, NH), 8.22 (d, J = 2.1 Hz, 1 H, H-4), 8.48 (d, J = 2.1 Hz, 1 H,
H-6).
13C NMR (63 MHz, CDCl3): d = 27.6 (CH3), 40.3 (Cq), 88.1 (Cq),
115.8 (Cq), 149.2 (C-4), 149.3 (C-6), 149.9 (Cq), 176.0 (Cq).
HRMS: m/z [M + H]+ calcd for C10H1379BrIN2O: 382.9256; found:
382.9263.
1-(2-Amino-5-bromopyridin-3-yl)ethanol (16)
Yield: 40 mg (8% over 3 steps); mp 171–172 °C
IR (KBr): 3634, 3444, 3266–3158, 2970–2857, 1675, 1622 cm–1.
1H NMR (250 MHz, CDCl3): d = 1.51 (d, J = 6.6 Hz, 3 H, CH3),
3.84 (br s, 1 H, OH), 4.24 (q, J = 6.6 Hz, 1 H, CHOH), 5.19 (br s,
2 H, NH2), 7.34 (d, J = 1.8 Hz, 1 H, H-4), 7.86 (d, J = 1.8 Hz, 1 H,
H-6).
13C NMR (63 MHz, CDCl3): d = 21.4 (CH3), 68.0 (CHOH), 107.7
4-Bromo-1H-pyrrolo[2,3-b]pyridine (7)
Prepared from commercially available 7-azaindole according to the
(Cq), 124.9 (Cq), 136.9 (C-4), 146.9 (C-6), 155.6 (Cq).
procedure described by Thibault and co-workers.4
HRMS: m/z [M + H]+ calcd for C7H1079BrN2O: 216.9976; found:
219.9984.
Preparation of Compound 8
A solution of pyridine 10 (1.0 g, 2.61 mmol), stannane mixture 11
and 12 (1.13 g, 3.13 mmol) and tetraethylammonium chloride
(0.433 g, 2.61 mmol) in MeCN (20 mL) was degassed 3 times with
Phenyl(1H-pyrrolo[2,3-b]pyridin-4-yl)methanol (17)
To a stirred solution of azaindole 7 (0.780 g, 3.96 mmol) in THF (9
mL) was added dropwise at –78 °C, MeLi (1.4 M in Et2O, 4 mL,
5.54 mmol). The mixture was stirred for 20 min at –78 °C then t-
BuLi (1.5 M in pentane, 6.6 mL, 9.9 mmol) was added. After stir-
ring for 15 min at –78 °C, benzaldehyde (2 mL, 19.8 mmol) was
added slowly. The mixture was allowed to warm slowly to r.t.,
stirred for 2 h then quenched with sat. NaHCO3 (10 mL) and ex-
tracted with CH2Cl2 (3 × 10 mL). The organic layers were dried
over MgSO4, filtered and evaporated under reduced pressure. The
crude product was purified by flash chromatography (PE–EtOAc,
1:1) to obtain the title azaindole 17.
argon. Dichlorobis(triphenylphosphine)palladium (0.073 g,
4
mol%) was added and the mixture was heated to reflux for 20 h. Af-
ter cooling to r.t., sat. KF (10 mL) and EtOAc (10 mL) were added
and this mixture was vigorously stirred for 30 min to precipitate the
tin salts. After filtration through celite, the filtrate was extracted
with EtOAc (2 × 20 mL) and the combined organic layers were
dried over MgSO4, filtered and evaporated. The crude oil, which ap-
peared to be a mixture of 13 and 14, was used without purification.
N-5-Bromo-3-[(E/Z)-2-ethoxyvinylpyridin-2-yl]-2,2-dimethyl-
propionamide (13)
Yield: 0.648 g (73%); yellow solid; mp 68–69 °C.
IR (KBr): 1125, 1224, 3320 cm–1.
1H NMR (250 MHz, DMSO-d6): d = 6.03 (br s, 2 H, CH and OH),
6.42 (d, J = 3.1 Hz, 1 H, H-3), 7.29–7.42 (m, 7 H, H-2, H-5 and
ArH), 8.17 (d, J = 5.0 Hz, 1 H, H-6), 11.50 (br s, 1 H, NH).
1H NMR (250 MHz, CDCl3): d = 1.32 (m, 24 H, CH3 cis and trans),
3.86 (q, J = 7.0 Hz, 2 H, CH2 trans), 4.02 (q, J = 7.0 Hz, 2 H, CH2
cis), 5.03 (d, J = 7.0 Hz, 1 H, CHenol cis), 5.54 (d, J = 12.8 Hz, 1 H,
CHenol trans), 6.36 (d, J = 7.0 Hz, 1 H, CHenol cis), 6.90 (d, J = 12.8
Hz, 1 H, CHenol trans), 7.71 (br s, 1 H, NH cis), 7.75 (d, J = 2.1 Hz,
1 H, H-4 trans), 7.93 (br s, 1 H, NH trans), 8.20 (d, J = 2.1 Hz, 1 H,
Synthesis 2008, No. 13, 2049–2054 © Thieme Stuttgart · New York